Grannus BioSciences LTD
Registered Offices
℅ Dundas and Wilson
191 West George Street,
Glasgow G2 2LD,
Scotland, U.K

• Privately held biotechnology company incorporated January 2004 under the Companies Acts in Scotland Registration Number SC240992

• Clinical stage novel anti-inflammatory products

• Exclusive World Wide License from the University of Glasgow to issued and pending patents

• Managed by Pharmetix Corp. of California, U.S.A.

• Corporate Counsel, Dundas & Wilson, Glasgow

www.grannusbiosciences.com
or contact
ir@grannusbiosciences.com
for more information

 

Grannus 2004-2005

• Grannus BioSciences Limited Announces Appointment of EGeen as CRO

• Grannus BioSciences Ltd. Announces Agreement for Preclinical and Clinical Stage Molecules

• Grannus receives a SCIS award from Targeting Innovation

• Grannus to file IND/CTA for human clinical testing

• Grannus receives Business Growth Fund Award from Scottish Enterprise

• Grannus receives Notice of Allowance in Australia and China for its patent applications

• Grannus appoints Iain McInnes and Robin Stevenson, Royal Infirmary Scotland and Dr. Minnie McMillan, USC School of Medicine to the Scientific Advisory Board


Grannus Shortcuts
Actinic Keratosis
Psoriasis
COPD
Press
Contact Information